title: Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
authors.affiliation: aDepartment of Clinical Pharmacy bDepartment of Internal Medicine/Infectious Diseases cDepartment of Internal Medicine/Nephrology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
authors.forename: Jacomien
authors.initials: J
authors.lastname: Aleman
authors.forename: Guido E L
authors.initials: GE
authors.lastname: van den Berk
authors.forename: Eric J F
authors.initials: EJ
authors.lastname: Franssen
authors.forename: Carola W H
authors.initials: CW
authors.lastname: de Fijter
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D060085:Coinfection / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications*; D015312:Hemodialysis Solutions / Q000737:chemistry; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D010530:Peritoneal Dialysis; D051437:Renal Insufficiency / Q000628:therapy*; D044967:Serum / Q000737:chemistry; D000068698:Tenofovir / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000998:Antiviral Agents; D015312:Hemodialysis Solutions; D000068698:Tenofovir